<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03379857</url>
  </required_header>
  <id_info>
    <org_study_id>6640</org_study_id>
    <nct_id>NCT03379857</nct_id>
  </id_info>
  <brief_title>Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke</brief_title>
  <acronym>CANNASTROKE</acronym>
  <official_title>Prevalence of Strokes Secondary to a Reversible Cerebral Vasoconstriction Attributable to Cannabis Consumption in Young Subjects (≤ 45 Years) Hospitalized for an Ischaemic Stroke</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Incidence of strokes has increased these last 20 years in young population. This rise could
      be linked to alcohol, tobacco or drug use like cannabis. Cannabis has previously been
      descripted as a potential factor of reversible vasoconstriction. The main objective is to
      show that an exhaustive assessment of a stroke facing a young person frequently lead to a
      diagnostic of reversible vasoconstriction due to cannabis use. Evaluation will focus on
      prevalence of strokes secondary to a reversible vasoconstriction attributable to cannabis in
      young subjects.

      There's a real public healthcare interest in terms of primary and secondary prevention to
      evaluate the role of cannabis as a risk factor of stroke in young population.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 11, 2018</start_date>
  <completion_date type="Anticipated">January 11, 2025</completion_date>
  <primary_completion_date type="Anticipated">January 11, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Cannabis User</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Evaluation Cannabis use</measure>
    <time_frame>12 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Reversible vasoconstriction on medical imaging of intracranial arteries at different moment</measure>
    <time_frame>12 months.</time_frame>
    <description>medical imaging of intracranial arteries will show new stenoses (topography, number, evolution), and new ischemic or cerebral haemorrhagic lesions</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Stroke</condition>
  <condition>Cannabis Use</condition>
  <arm_group>
    <arm_group_label>Cannabis User</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Drug urinal test</intervention_name>
    <description>Non Applicable</description>
    <arm_group_label>Cannabis User</arm_group_label>
    <other_name>Magnetic Resonance Imaging</other_name>
    <other_name>Computerized Tomography Scan</other_name>
    <other_name>Transcranial Doppler Ultrasound</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Subject between 18 and 45 years old

          -  Stroke confirmed by medical imaging

          -  Written informed consent (subject, nearby or emergency procedure)

          -  Subject affiliate to a local healthcare insurance office

          -  For female of childbearing potential, an adequate contraceptive measur

        Exclusion Criteria:

          -  Subject with psychiatric disorder, unable to understand the study or cooperate

          -  Subject under guardianship or forfeiture of liberty

          -  Pregnant or breastfeeding woman

          -  Subject in period of exclusion due to another study or still in follow-up of an
             interventional study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valérie WOLFF, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hôpitaux Universitaires de Strasbourg</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valérie WOLFF, MD</last_name>
    <phone>+33 3 88 12 86 06</phone>
    <email>valerie.wolff@chru-strasbourg.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Chu Jean Minjoz</name>
      <address>
        <city>Besancon</city>
        <zip>25030</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry MOULIN</last_name>
      <phone>+33 3 81 66 84 38</phone>
      <email>thierry.moulin@univ-fcomte.fr</email>
    </contact>
    <investigator>
      <last_name>Thierry MOULIN</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Unite Neuro-Vasculaire</name>
      <address>
        <city>Colmar</city>
        <zip>68024</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francis VUILLEMET</last_name>
      <phone>+33 3 89 12 41 50</phone>
      <email>francis.vuillemet@ch-colmar.fr</email>
    </contact>
    <investigator>
      <last_name>Francis VUILLEMET</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chu Bocage</name>
      <address>
        <city>Dijon</city>
        <zip>21079</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Yannick BEJOT</last_name>
      <phone>+33 3 80 29 37 53</phone>
      <email>yannick.bejot@chu-dijon.fr</email>
    </contact>
    <investigator>
      <last_name>Yannick BEJOT</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>C.H. G. Muller</name>
      <address>
        <city>Mulhouse</city>
        <zip>68070</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric SCHLUCK</last_name>
      <phone>+33 3 89 64 61 81</phone>
      <email>schlucke@ch-mulhouse.fr</email>
    </contact>
    <investigator>
      <last_name>Eric SCHLUCK</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hopital Central</name>
      <address>
        <city>Nancy</city>
        <zip>54035</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sébastien RICHARD</last_name>
      <phone>+33 3 83 85 22 56</phone>
      <email>s.richard@chru-nancy.fr</email>
    </contact>
    <investigator>
      <last_name>Sébastien RICHARD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Les Hôpitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67098</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valérie WOLFF, MD</last_name>
      <phone>33 3 88 12 86 06</phone>
      <email>valerie.wolff@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Valérie WOLFF, M</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie LAUER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simona SABAU PHILIPPI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mihaela DIACONU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Danièla BINDILA</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Lelyzaveta ZINCHENKO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique QUENARDELLE</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stéphane KREMER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>September 29, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2017</study_first_posted>
  <last_update_submitted>June 11, 2019</last_update_submitted>
  <last_update_submitted_qc>June 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 13, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Marijuana Abuse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

